Loading company…
Riskpilot
← Back to search
Sign in
Get full access
SCHEIENE NEUROCONSULT AS
AS
Active
Org 933038467
Årvollveien 60K, 0590 Oslo
All other professional, scientific and technical activities n.e.c. · NACE 7499
Est. 2024
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
NOK 1,2M
+176% vs 2024
EBITDA margin
-0.4%
-131% vs 2024
Equity ratio
-5.3%
Financial strength
Net profit 2025
NOK -4K
-127% vs 2024
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
NOK 1,2M
+176%
EBITDA
NOK -4K
-131%
Net profit
NOK -4K
-127%
Total assets
NOK 106K
+7%
Equity
NOK -6K
-115%
Employees
0
—
Company information
Legal name
SCHEIENE NEUROCONSULT AS
Org number
933038467
Legal form
Aksjeselskap
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
20. februar 2024
Share capital
NOK 30 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder eller styrets leder hver for seg.
Company purpose
Kursvirksomhet, klinisk arbeid, testutvikling, rådgivning og veiledning innen nevropsykologi.
Contact
Address
Årvollveien 60K, 0590 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in All other professional, scientific and technical activities n.e.c.
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2024
1M
2025
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2024
0M
2025
Income statement
NOK thousands
Item
2024
2025
Revenue
418
1 155
Staff expenses
−259
−861
EBITDA
13
−4
Depreciation & amort.
−0
−0
EBIT
13
−4
Net financials
0
1
Profit before tax
13
−4
Tax
−0
0
Net profit
13
−4
Balance sheet
NOK thousands
Item
2024
2025
Total assets
99
106
Equity
37
−6
Long-term debt
0
0
Short-term debt
62
112
Total debt
62
112
Financial ratios
5-year trend
EBITDA margin
-0.4%
This company
15.8%
Market median
-103% vs market
2024
2025
Equity ratio
-5.3%
This company
38.2%
Market median
-114% vs market
2024
2025
Return on equity
-355500.0%
This company
18.4%
Market median
-1932165% vs market
2024
2025
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
2024
2025
Asset turnover
10.87×
This company
1.12×
Market median
+871% vs market
2024
2025
Debt / equity
19.93×
This company
0.62×
Market median
-3115% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-18 – 2024-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
MS
Martin Scheiene
Chairman
2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of SCHEIENE NEUROCONSULT AS also hold positions in
0
other companies.
Person
Role here
Other companies
Martin Scheiene
Chairman
0 companies